Nuveen’s Takeda Pharmaceutical TAK Stock Holding History

Nuveen’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79M	Buy	+174,356	New	+$2.89M	﹤0.01%	2407
2024 Q2	–	Sell	-74,190	Closed	-$1.05M	–	3413
2024 Q1	$1.05M	Buy	74,190 +3,390	+5%	+$49.3K	﹤0.01%	2683
2023 Q4	$1.01M	Buy	70,800 +69,868	+7,497%	+$991K	﹤0.01%	2732
2023 Q3	$14.4K	Buy	+932	New	+$14.4K	﹤0.01%	3180
2022 Q1	–	Sell	-583,493	Closed	-$7.95M	–	3422
2021 Q4	$7.95M	Sell	583,493 -1,320,181	-69%	-$18.5M	﹤0.01%	1826
2021 Q3	$31.2M	Sell	1,903,674 -31,391	-2%	-$527K	0.01%	964
2021 Q2	$32.6M	Buy	1,935,065 +247,697	+15%	+$4.22M	0.01%	1010
2021 Q1	$30.8M	Buy	1,687,368 +462,051	+38%	+$8.31M	0.01%	1015
2020 Q4	$22.3M	Buy	+1,225,317	New	+$21.5M	0.01%	1194
2020 Q1	–	Sell	-67,708	Closed	-$1.34M	–	3259
2019 Q4	$1.34M	Hold	67,708	–	–	﹤0.01%	2583
2019 Q3	$1.17M	Hold	67,708	–	–	﹤0.01%	2632
2019 Q2	$1.2M	Buy	+67,708	New	+$1.23M	﹤0.01%	2663

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Nuveen's TAK Position: Q2 2026 in Review

Nuveen opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 174,356 shares worth $2.79M. The stake represents ﹤0.01% of the portfolio and ranks #2407 among its holdings. This is a return to the name: Nuveen previously reported a position in TAK as recently as Q1 2024.

Nuveen first reported a position in TAK in Q2 2019 and has held it in 12 quarters since. The position peaked at $32.6M in Q2 2021. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Nuveen held 174,356 shares of Takeda Pharmaceutical worth $2.79M as of Q2 2026.
Takeda Pharmaceutical was a new Nuveen position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2407 holding.
Nuveen first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 12 quarters since.
Nuveen's Takeda Pharmaceutical position peaked at $32.6M in Q2 2021.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.